In novel coronavirus pneumonia, the US government said in August 13th that if the new crown pneumonia vaccine were proven effective, the United States would ensure free distribution to all Americans, and emphasized that "no shortcut" would be achieved in vaccine safety.Paul Mungo (Paul Mango), a senior official in the U.S. Department of Health and Human Services, told reporters that the price of the vaccine dose itself would be paid by the government, and that doctors or clinics that manage the vaccine would have to pay, but most of these costs should be paid by private and public insurance companies.
Mungo said that "most" commercial insurance companies have agreed to waive any out-of-pocket charges for customers. "We are planning to deliver hundreds of millions of doses by January 2021," he added.
It is reported that since May this year, the U.S. government has signed pre purchase agreements with at least six global pharmaceutical companies, including Pfizer Pharmaceutical Co., Ltd., Novavax Co., Ltd., Modena company of the United States, new biotechnology company of Germany, aslicon of the United Kingdom, etc., with a total contract amount of more than 10 billion US dollars to ensure approval after clinical trials Hundreds of millions of doses of vaccine were delivered.
American President Donald Trump (Donald Trump) announced in May the launch of a program called "Operation Tramp" to accelerate research on new crown vaccines, drugs, testing, and so on, with all Americans expected to a new crown vaccine by January next year. Stimulated by the plan, tens of millions of dollars went to vaccine research and development institutions.
At the same time, in response to concerns about the safety of the vaccine developed, Mungo said: "we have not in the least reduced the regulatory rigour of evaluating and wanting to approve vaccines."
Francis Collins (Francis Collins), president of the National Institutes of Health (NIH), said he was "cautiously optimistic" that at least one of the six vaccines invested in the United States would be passed by the end of the year.
However, Trump's critics say the U.S. government may bypass safety precautions and announce vaccine availability before the November 3 election. Mungo denied the "charge ".